Remestemcel-L Completed Phase 3 Trials for Crohn's Disease (CD) Treatment

Back to Remestemcel-L
IndicationsStatusPurposePhase
CompletedTreatment3
clinicaltrials.gov IdentifierTitleDrugs
NCT01233960Evaluation of PROCHYMAL® for Treatment-refractory Moderate-to-severe Crohn's Disease
NCT00543374Extended Evaluation of PROCHYMAL® Adult Human Stem Cells for Treatment-Resistant Moderate-to-Severe Crohn's Disease
NCT00482092Evaluation of PROCHYMAL® Adult Human Stem Cells for Treatment-resistant Moderate-to-severe Crohn's Disease